Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00817999 · ClinicalTrials.gov registry record · Phase 4
The Impact of Grapefruit Juice on the Response to Clopidogrel
A Phase 4 study, sponsored by Creighton University.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT00817999 is a Phase 4 study that has completed, run by Creighton University. The registered enrollment target is 32 participants.
The verdict
NCT00817999, a Phase 4 study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study will measure the percentage of platelet aggregation inhibition with a loading dose of clopidogrel (300 mg) using the VerifyNow Assay System in healthy volunteers who have drank 11 oz of grapefruit juice. It will also measure the percentage of platelet aggregation inhibition with a maintenance dose of clopidogrel (75 mg/day) using the VerifyNow Assay System in healthy volunteers who have drank 11 oz grapefruit juice daily.
Interventions
- DIETARY_SUPPLEMENT Grapefruit juice
- DRUG Clopidogrel 75 mg/day
- DRUG Clopidogrel 300 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00817999
The ClinicalTrials.gov registry entry for NCT00817999 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Grapefruit juice is the first listed.
NCT00817999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00817999 about?
NCT00817999 is a clinical study titled "The Impact of Grapefruit Juice on the Response to Clopidogrel". This study will measure the percentage of platelet aggregation inhibition with a loading dose of clopidogrel (300 mg) using the VerifyNow Assay System in healthy volunteers who have drank 11 oz of grapefruit juice. It will also measure the percentage of platelet aggregation inhibition with a mainten...
What is the current status of trial NCT00817999?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2008-11. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00817999?
The interventions under investigation include: Grapefruit juice (DIETARY_SUPPLEMENT), Clopidogrel 75 mg/day (DRUG), Clopidogrel 300 mg (DRUG).
Who is sponsoring clinical trial NCT00817999?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.